Project Details
Description
An interventional Phase 3, open-label, two-cohort study to investigate the efficacy and safety of fosmanogepix in adult patients with invasive mold infections caused by...
| Status | Active |
|---|---|
| Effective start/end date | 4/7/25 → 4/6/36 |
Funding
- BASILEA PHARMACEUTICA INTERNATIONAL LTD
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.